These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33163486)

  • 1. Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease.
    Schroth J; Thiemermann C; Henson SM
    Front Cell Dev Biol; 2020; 8():564461. PubMed ID: 33163486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ageing, cellular senescence and chronic kidney disease: experimental evidence.
    Tan H; Xu J; Liu Y
    Curr Opin Nephrol Hypertens; 2022 May; 31(3):235-243. PubMed ID: 35142744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-derived exosomes promote telomere fragility and senescence in tubular epithelial cells by delivering miR-155.
    Yin Q; Tang TT; Lu XY; Ni WJ; Yin D; Zhang YL; Jiang W; Zhang Y; Li ZL; Wen Y; Gan WH; Zhang AQ; Lv LL; Wang B; Liu BC
    Cell Commun Signal; 2024 Jul; 22(1):357. PubMed ID: 38987851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials.
    Franzin R; Stasi A; Ranieri E; Netti GS; Cantaluppi V; Gesualdo L; Stallone G; Castellano G
    Front Pharmacol; 2021; 12():630419. PubMed ID: 33995028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence.
    Li C; Shen Y; Huang L; Liu C; Wang J
    FASEB J; 2021 Jan; 35(1):e21229. PubMed ID: 33368613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.
    Xu J; Zhou L; Liu Y
    Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
    Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
    Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.
    Wang WJ; Cai GY; Chen XM
    Oncotarget; 2017 Sep; 8(38):64520-64533. PubMed ID: 28969091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Senescent Cells as Therapy for CKD.
    Mylonas KJ; Ferenbach DA
    Kidney360; 2024 Jan; 5(1):142-151. PubMed ID: 38049936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senopathies-Diseases Associated with Cellular Senescence.
    Lushchak O; Schosserer M; Grillari J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting senescent cells: approaches, opportunities, challenges.
    von Kobbe C
    Aging (Albany NY); 2019 Nov; 11(24):12844-12861. PubMed ID: 31789602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies.
    Wang Y; Wang Y; Yang M; Ma X
    Biomed Pharmacother; 2021 Mar; 135():111191. PubMed ID: 33418306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
    Basisty N; Kale A; Patel S; Campisi J; Schilling B
    Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of senescence on muscle wasting in chronic kidney disease.
    Huang Y; Wang B; Hassounah F; Price SR; Klein J; Mohamed TMA; Wang Y; Park J; Cai H; Zhang X; Wang XH
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):126-141. PubMed ID: 36351875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management.
    Phillips PCA; de Sousa Loreto Aresta Branco M; Cliff CL; Ward JK; Squires PE; Hills CE
    Diabet Med; 2024 Jul; ():e15408. PubMed ID: 38995865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress and Cellular Senescence Are Involved in the Aging Kidney.
    Marquez-Exposito L; Tejedor-Santamaria L; Valentijn FA; Tejera-Muñoz A; Rayego-Mateos S; Marchant V; Rodrigues-Diez RR; Rubio-Soto I; Knoppert SN; Ortiz A; Ramos AM; Goldschmeding R; Ruiz-Ortega M
    Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.